paragraph

Glenmark Pharma vs Aurobindo Pharma: The difference that matters

Both Glenmark Pharma and Aurobindo Pharma have given massive returns to investors in the past one year with Glenmark surging 120 percent and Aurobindo gaining 64 percent in the same period. Meanwhile, the pharma majors surged 104 percent each in 2023 YTD.

General insurance trend 2023: Private players continue to gain shares from PSU players

Ganesh Chaturthi: Money lessons to learn from the God of Wisdom

Best aggressive hybrid mutual funds to invest in 2023

Highest fixed deposit interest rates for senior citizens

Best multi-asset allocation funds to invest in 2023

84% of Indian investors' net worth increased in past three years

Mutual Funds: Large cap schemes beating benchmark returns

PI Industries vs Navin Fluorine: Which is a better stock to invest?

Shining star: 40 SME companies trading over 100% in 2023

MF central: Manage accounts with multiple fund houses at one unified platform; Here's how

Holding a number of mutual funds in a number of AMCs is not uncommon. It is, therefore, vital to manage all accounts with ease and comfort

Stock Check: JSW Infra jumps almost 100% from IPO price in 5 months; should you still buy?

Currently trading at around  <span class='webrupee'>₹</span>236, the newly listed JSW Infra has surged almost 100 percent jump from its IPO price of  <span class='webrupee'>₹</span>119 in less than 5 months. Technical and fundamental experts suggest if you should still buy the infra stock.

Axis Mobile App ranks top position on NPS leaderboard

According to a survey, Consumer awareness was most notable for payment platforms such as Paytm, Google Pay, and PhonePe. However, when it comes to Net Promoter Score, Axis Mobile App claims the top position with a score of 59, followed by ICICI Bank's iMobile Pay, and then BHIM.

Weekend Wrap: From Trent to Adani Power, top news and market movers this week: 27 October 2023

The stock market cycle is always a few months ahead of the economic cycle.

From top news makers to market performance, here's the market wrap for the week ended 27 October 2023.

Why rebalancing a portfolio provides a safety net against volatility?

Investing isn't a 'set it and forget it' game.

Rebalancing a portfolio provides a safety net by helping control volatility and minimizing the impact of market downturns, even though it may not always yield higher returns compared to an unbalanced, equity-heavy approach

Glenmark Pharma vs Aurobindo Pharma: The difference that matters

Both Glenmark Pharma and Aurobindo Pharma have given massive returns to investors in the past one year with Glenmark surging 120 percent and Aurobindo gaining 64 percent in the same period. Meanwhile, the pharma majors surged 104 percent each in 2023 YTD.

Topics to follow